619 related articles for article (PubMed ID: 29967265)
21. PD-1 blockade enhances radio-immunotherapy efficacy in murine tumor models.
Zhuang Y; Li S; Wang H; Pi J; Xing Y; Li G
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1909-1920. PubMed ID: 30074066
[TBL] [Abstract][Full Text] [Related]
22. JMJD6 in tumor-associated macrophage regulates macrophage polarization and cancer progression via STAT3/IL-10 axis.
Chen S; Wang M; Lu T; Liu Y; Hong W; He X; Cheng Y; Liu J; Wei Y; Wei X
Oncogene; 2023 Sep; 42(37):2737-2750. PubMed ID: 37567973
[TBL] [Abstract][Full Text] [Related]
23. Tumor suppressor ARF regulates tissue microenvironment and tumor growth through modulation of macrophage polarization.
Jiménez-García L; Herranz S; Higueras MA; Luque A; Hortelano S
Oncotarget; 2016 Oct; 7(41):66835-66850. PubMed ID: 27572316
[TBL] [Abstract][Full Text] [Related]
24. Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy.
Lan J; Li R; Yin LM; Deng L; Gui J; Chen BQ; Zhou L; Meng MB; Huang QR; Mo XM; Wei YQ; Lu B; Dicker A; Xue JX; Lu Y
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):74-87. PubMed ID: 29619980
[TBL] [Abstract][Full Text] [Related]
25. Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia.
Salik B; Yi H; Hassan N; Santiappillai N; Vick B; Connerty P; Duly A; Trahair T; Woo AJ; Beck D; Liu T; Spiekermann K; Jeremias I; Wang J; Kavallaris M; Haber M; Norris MD; Liebermann DA; D'Andrea RJ; Murriel C; Wang JY
Cancer Cell; 2020 Aug; 38(2):263-278.e6. PubMed ID: 32559496
[TBL] [Abstract][Full Text] [Related]
26. Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment.
Cekic C; Day YJ; Sag D; Linden J
Cancer Res; 2014 Dec; 74(24):7250-9. PubMed ID: 25377469
[TBL] [Abstract][Full Text] [Related]
27. Reconstitution of R-spondin:LGR4:ZNRF3 adult stem cell growth factor signaling complexes with recombinant proteins produced in Escherichia coli.
Moad HE; Pioszak AA
Biochemistry; 2013 Oct; 52(41):7295-304. PubMed ID: 24050775
[TBL] [Abstract][Full Text] [Related]
28. The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade.
Li HY; McSharry M; Bullock B; Nguyen TT; Kwak J; Poczobutt JM; Sippel TR; Heasley LE; Weiser-Evans MC; Clambey ET; Nemenoff RA
Cancer Immunol Res; 2017 Sep; 5(9):767-777. PubMed ID: 28819064
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types.
Chartier C; Raval J; Axelrod F; Bond C; Cain J; Dee-Hoskins C; Ma S; Fischer MM; Shah J; Wei J; Ji M; Lam A; Stroud M; Yen WC; Yeung P; Cancilla B; O'Young G; Wang M; Kapoun AM; Lewicki J; Hoey T; Gurney A
Cancer Res; 2016 Feb; 76(3):713-23. PubMed ID: 26719531
[TBL] [Abstract][Full Text] [Related]
30. A MyD88/IL1R Axis Regulates PD-1 Expression on Tumor-Associated Macrophages and Sustains Their Immunosuppressive Function in Melanoma.
Tartey S; Neale G; Vogel P; Malireddi RKS; Kanneganti TD
Cancer Res; 2021 May; 81(9):2358-2372. PubMed ID: 33619117
[TBL] [Abstract][Full Text] [Related]
31. Local Activation of p53 in the Tumor Microenvironment Overcomes Immune Suppression and Enhances Antitumor Immunity.
Guo G; Yu M; Xiao W; Celis E; Cui Y
Cancer Res; 2017 May; 77(9):2292-2305. PubMed ID: 28280037
[TBL] [Abstract][Full Text] [Related]
32. Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
Lacal PM; Atzori MG; Ruffini F; Scimeca M; Bonanno E; Cicconi R; Mattei M; Bernardini R; D'Atri S; Tentori L; Graziani G
Pharmacol Res; 2020 Sep; 159():104957. PubMed ID: 32485280
[TBL] [Abstract][Full Text] [Related]
33. GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models.
Torphy RJ; Sun Y; Lin R; Caffrey-Carr A; Fujiwara Y; Ho F; Miller EN; McCarter MD; Lyons TR; Schulick RD; Kedl RM; Zhu Y
Nat Commun; 2022 Jan; 13(1):97. PubMed ID: 35013216
[TBL] [Abstract][Full Text] [Related]
34. Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN/PI3Kγ to Promote Pancreatic Cancer Metastasis.
Wang X; Luo G; Zhang K; Cao J; Huang C; Jiang T; Liu B; Su L; Qiu Z
Cancer Res; 2018 Aug; 78(16):4586-4598. PubMed ID: 29880482
[TBL] [Abstract][Full Text] [Related]
35. STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation.
Lemos H; Mohamed E; Huang L; Ou R; Pacholczyk G; Arbab AS; Munn D; Mellor AL
Cancer Res; 2016 Apr; 76(8):2076-81. PubMed ID: 26964621
[TBL] [Abstract][Full Text] [Related]
36. Multifunctional biomimetic nanoparticles loading baicalin for polarizing tumor-associated macrophages.
Han S; Wang W; Wang S; Wang S; Ju R; Pan Z; Yang T; Zhang G; Wang H; Wang L
Nanoscale; 2019 Nov; 11(42):20206-20220. PubMed ID: 31621735
[TBL] [Abstract][Full Text] [Related]
37. Afatinib Exerts Immunomodulatory Effects by Targeting the Pyrimidine Biosynthesis Enzyme CAD.
Tu HF; Ko CJ; Lee CT; Lee CF; Lan SW; Lin HH; Lin HY; Ku CC; Lee DY; Chen IC; Chuang YH; Del Caño-Ochoa F; Ramón-Maiques S; Ho CC; Lee MS; Chang GD
Cancer Res; 2021 Jun; 81(12):3270-3282. PubMed ID: 33771897
[TBL] [Abstract][Full Text] [Related]
38. Macrophage-Derived Neuropilin-2 Exhibits Novel Tumor-Promoting Functions.
Roy S; Bag AK; Dutta S; Polavaram NS; Islam R; Schellenburg S; Banwait J; Guda C; Ran S; Hollingsworth MA; Singh RK; Talmadge JE; Muders MH; Batra SK; Datta K
Cancer Res; 2018 Oct; 78(19):5600-5617. PubMed ID: 30111533
[TBL] [Abstract][Full Text] [Related]
39. P2X7 Receptor Activity Limits Accumulation of T Cells within Tumors.
Romagnani A; Rottoli E; Mazza EMC; Rezzonico-Jost T; De Ponte Conti B; Proietti M; Perotti M; Civanelli E; Perruzza L; Catapano AL; Baragetti A; Tenedini E; Tagliafico E; Falzoni S; Di Virgilio F; Norata GD; Bicciato S; Grassi F
Cancer Res; 2020 Sep; 80(18):3906-3919. PubMed ID: 32699136
[TBL] [Abstract][Full Text] [Related]
40. Regulation of the follistatin gene by RSPO-LGR4 signaling via activation of the WNT/β-catenin pathway in skeletal myogenesis.
Han XH; Jin YR; Tan L; Kosciuk T; Lee JS; Yoon JK
Mol Cell Biol; 2014 Feb; 34(4):752-64. PubMed ID: 24344199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
